Discover 36 paid clinical trials in Fargo, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Neuropsychiatric Research Institute, Fargo, North Dakota
Location:
Code:
NCT02370732
Conditions
Bariatric Surgery Candidate
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Accepted
Interventions
Alcohol
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312137
Conditions
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Cisplatin
Pemetrexed
Gemcitabine
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT04165070
Conditions
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Carboplatin
Paclitaxel
Pemetrexed
Vibostolimab
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT05746559
Conditions
Chronic Kidney Disease
CKD
Cardiac Disease
Cardiopulmonary Bypass
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
Ravulizumab
Sponsor:
MoonLake Immunotherapeutics AG
Location:
Code:
NCT06411379
Conditions
Hidradenitis Suppurativa
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sonelokimab
Placebo
Sponsor:
Andover Eye Associates
Location:
Code:
NCT04296864
Conditions
Atopic Keratoconjunctivitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dupilumab
Sponsor:
Sanofi
Location:
Code:
NCT06790121
Conditions
Dermatitis Atopic
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Lunsekimig
Placebo
Sponsor:
Sanofi
Location:
Code:
NCT05263206
Conditions
Pruritus
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Dupilumab
Placebo
Fexofenadine (loratadine if not available)
Moisturizer
Sponsor:
Insud Pharma
Location:
Code:
NCT05303636
Conditions
Change in Bone Mineral Density
Bone Loss
Eligibility Criteria
Sex: Female
Age: 14 - 45
Healthy Volunteers: Accepted
Interventions
LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet